Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy

Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy

Background: The high cost of CD4 count estimation in resource-limited settings is a major obstacle in initiating patients on highly active antiretroviral therapy (HAART). Thus, there is a need to evaluate other less expensive surrogate markers like total lymphocyte count (TLC) and absolute lymphocyt...

Full description

Bibliographic Details
Main Authors: Srirangaraj Sreenivasan, Venkatesha Dasegowda
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Journal of Global Infectious Diseases
Subjects:
Absolute lymphocyte count
Total lymphocyte count
CD4 counts
HAART
Surrogate marker
Online Access:http://www.jgid.org/article.asp?issn=0974-777X;year=2011;volume=3;issue=3;spage=265;epage=268;aulast=Sreenivasan

Internet

http://www.jgid.org/article.asp?issn=0974-777X;year=2011;volume=3;issue=3;spage=265;epage=268;aulast=Sreenivasan

Similar Items